Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Biocardia Inc (BCDA)

Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results GlobeNewswire - Wed Aug 12, 3:05PM CDT

SUNNYVALE, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc.  [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BCDA : 0.9784 (+1.17%)
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026 GlobeNewswire - Wed Aug 5, 2:16PM CDT

SUNNYVALE, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BCDA : 0.9784 (+1.17%)
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities GlobeNewswire - Thu Jun 18, 7:00AM CDT

SUNNYVALE, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA],  a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

BCDA : 0.9784 (+1.17%)
BioCardia Announces $4.4 Million Financing GlobeNewswire - Mon Jun 8, 7:00AM CDT

Net proceeds anticipated to extend cash runway into first quarter of 2027 beyond expected Japan PMDA submission; if currently outstanding warrants issued in previous financings are exercised in full for...

BCDA : 0.9784 (+1.17%)
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF GlobeNewswire - Fri Jun 5, 7:00AM CDT

SUNNYVALE, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BCDA : 0.9784 (+1.17%)
BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure GlobeNewswire - Thu May 28, 7:00AM CDT

SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BCDA : 0.9784 (+1.17%)
BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency GlobeNewswire - Thu May 21, 7:00AM CDT

– Positive CardiAMP CMI Trial open-label cohort results demonstrated opportunity for locally delivered cell therapy to enhance therapeutic options for patients with severely symptomatic refractory angina...

BCDA : 0.9784 (+1.17%)
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase GlobeNewswire - Tue May 19, 7:00AM CDT

SUNNYVALE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc.  [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BCDA : 0.9784 (+1.17%)
BioCardia Reports First Quarter 2026 Business Highlights and Financial Results GlobeNewswire - Fri May 15, 7:00AM CDT

SUNNYVALE, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc.  [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BCDA : 0.9784 (+1.17%)
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026 GlobeNewswire - Mon May 11, 4:10PM CDT

SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

BCDA : 0.9784 (+1.17%)

Barchart Exclusives

NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough Barchart - 16 minutes ago
NVAX stock surges amid biotech stock rally following Moderna and Merck cancer breakthrough. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.